[Determination of fucokinase activity in the blood of schizophrenic patients].
An investigation was conducted into whether dopamine induces an alteration in the fucolysation of glycoproteins, starting from the dopamine hypothesis of schizophrenia and taking the fucokinase activity determined in erythrocytes of schizophrenic patients as parameter. As with patients with "schizoaffective psychosis" and those with manic-depressive disorders, who were likewise examined, it was found that the enzyme activity of schizophrenic patients was no different than that found in the blood of a control group.
Honza
A
A
Klinik für Neurologie und Psychiatrie, Medizinischen Akademie Magdeburg.
Jork
R
R
Müller
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D004912:Erythrocytes / Q000201:enzymology*; D006801:Humans; D008875:Middle Aged; D009497:Neurotic Disorders / Q000201:enzymology; D010770:Phosphotransferases / Q000097:blood*; D017853:Phosphotransferases (Alcohol Group Acceptor); D010865:Pilot Projects; D011843:Radiculopathy / Q000201:enzymology; D012559:Schizophrenia / Q000201:enzymology*
D010770:Phosphotransferases; D017853:Phosphotransferases (Alcohol Group Acceptor); C020153:fucokinase
Bestimmung der Fukokinaseaktivität im Blut schizophrener Patienten.